EMA: ‘No Going Back’ On Decentralized Trials
A senior official from the European Medicines Agency says the COVID-19 pandemic has changed the future clinical trials landscape for good.
A senior official from the European Medicines Agency says the COVID-19 pandemic has changed the future clinical trials landscape for good.